Investing Profile

Paul Walker

VCInvestor
General Partner at New Enterprise Associates (NEA)
nea.com/team/paul-walkerMenlo Park, California
Photo of Paul Walker, General Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$2.0M - $50.0M
$25.0M
20
$6.2B
CompanyStageDateRound SizeTotal Raised
Allakos
Post Ipo EquitySep 2022$150M
Series BDec 2017$100M
$280M
Co-investors: John McKearn (RiverVest), Farah Champsi (InterWest)
Regulus Therapeutics
Post Ipo EquityNov 2021$35M
Post Ipo EquityJan 2017
$35M
Geron
Post Ipo EquityJan 2020
erytech
Post Ipo EquityJan 2020
€12M
Co-investors: Catherine Boule (Karista)
Xenon Pharmaceuticals
Post Ipo EquityJan 2019
Co-investors: Blake Wu (New Enterprise Associates (NEA))
CTI BioPharma
Post Ipo EquityJan 2018
Addex Therapeutics
Post Ipo EquityFeb 2017$3M
$3M
€10M
Co-investors: Antoine Papiernik Papiernik (Soffinova Partners)
Immunomedics
Post Ipo EquityJan 2017